The Biologics News and Reports Portal

Show Cart

All Products

Results 161 - 171 of 171

Sep 2010 Coagulation Factors 2010 - The Portfolio Aspect as Decisive Force: A Competitive Landscape and R&D Pipeline Analysis of Hemostasis Proteins

2,495.00 €

Aug 2009 Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis

2,450.00 €

Apr 2009 Competitor Analysis: Hypoxia-Inducible Factor (HIF)

100.00 €

Sep 2008 Competitor Analysis: HDL Raising Therapies

250.00 €

Oct 2005 R&D Pipeline News - Technology Edition: 1-Yr Subscription

900.00 €

Oct 2005 R&D Pipeline News - Therapeutic Area Edition: 1-Yr Subscription

900.00 €

Start
Prev
1
2
3
4
5
6
7
8
9
Next
End

Shopping cart

Cart empty

Latest report

T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis

Featured Products

Report Package: TCR-Based Antibody and T-Cell Immunotherapy

TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals

Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends

Latest Target Pipeline

CD38-Targeted Antibody & Cell Therapy

Shopping cart

Cart empty

Latest report

T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis

Featured Products

Report Package: TCR-Based Antibody and T-Cell Immunotherapy

TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals

Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends

All Products

May 2011 Competitor Analysis: Influenza Vaccines

Apr 2011 Competitor Analysis: Targeted Therapy of Diabetes

Apr 2011 Competitor Analysis: Emerging Diabetes Drugs

Mar 2011 Competitor Analysis: Targeted Therapy of Obesity

Nov 2010 Antibody Technology Companies 2010

Sep 2010 Coagulation Factors 2010 - The Portfolio Aspect as Decisive Force: A Competitive Landscape and R&D Pipeline Analysis of Hemostasis Proteins

Aug 2009 Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis

Apr 2009 Competitor Analysis: Hypoxia-Inducible Factor (HIF)

Sep 2008 Competitor Analysis: HDL Raising Therapies

Oct 2005 R&D Pipeline News - Technology Edition: 1-Yr Subscription

Oct 2005 R&D Pipeline News - Therapeutic Area Edition: 1-Yr Subscription

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

La Merie Biologics

FREE Weekly News Bulletin

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing